Lemaitre Vascular (LMAT) Non-Current Deferred Tax Liability (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Non-Current Deferred Tax Liability came in at $1.9 million in Q1 2026, up 2007.95% year-on-year from $88000.0 in Q1 2025, and up 6.92% on a QoQ basis from $1.7 million in Q4 2025.
Lemaitre Vascular (LMAT) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Non-Current Deferred Tax Liability data on file, last reported at $1.9 million in Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 2007.95% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 2007.95% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 1941.18% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $1.9 million, up from $1.7 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for LMAT reached as high as $2.1 million in Q3 2025 and fell as low as $60000.0 in Q3 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $403117.6 across 5 years, with a median of $88000.0 in 2025.
- Across the five-year window, Non-Current Deferred Tax Liability tumbled 50.82% in 2022 and jumped 2007.95% in 2026, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $69000.0 in 2022, then surged by 55.07% to $107000.0 in 2023, then decreased by 20.56% to $85000.0 in 2024, then surged by 1941.18% to $1.7 million in 2025, then grew by 6.92% to $1.9 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $1.9 million in Q1 2026, $1.7 million in Q4 2025, and $2.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.86 Mn |
| Mar 31, 2026 | 1.86 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 95,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 85,000.00 |
| Dec 31, 2024 | 85,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 114,000.00 |
| Mar 31, 2024 | 114,000.00 |
| Dec 31, 2023 | 107,000.00 |
| Dec 31, 2023 | 107,000.00 |